Please login to the form below

Not currently logged in


This page shows the latest Tavlesse news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Grifols’ Tavlesse for chronic immune thrombocytopenia

NICE recommends Grifols’ Tavlesse for chronic immune thrombocytopenia

The agency’s recommendation was based on cost-effectiveness estimates of Tavlesse compared with rituximab. ... Tavlesse] will be another tool for haematologists to use in supporting patients with chronic ITP.”.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Time to talk about health inequalities
Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
The speed of science and the pace of comms
Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...